Airsculpt Technologies, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $151.8 | $180.3 | $195.9 | $168.8 | $133.3 |
| Operating income | -$11.6 | -$1.6 | $9.7 | -$4.5 | $15.8 |
| Net income | -$11.7 | -$8.0 | -$4.2 | -$14.7 | $10.6 |
| Balance Sheet | |||||
| Total debt | $57.0 | $70.8 | $72.9 | $85.0 | $84.3 |
| Cash Flow Statement | |||||
| Free cash flow | $0.7 | -$2.7 | $14.0 | $11.5 | $19.5 |
| Dividends | $0.0 | $0.3 | $0.4 | $23.2 | $0.0 |
Shares outstanding 72.1M · Free float 46.6%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.
Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
July 4, 2026
Filings Beige Book
Companies Report Firm Demand, Relentless Cost Pressure